Cephalon Email Formats

Pharmaceutical Manufacturing • United States • 501-1000 Employees

Cephalon Email Formats

Cephalon uses 5 email formats. The most common is {first initial}.{last name} (e.g., j.doe@tevapharm.com), used 32.5% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@tevapharm.com	32.5%
{first name}	john@tevapharm.com	22.5%
{last name}	doe@tevapharm.com	20%
{first initial}{last name}	jdoe@cephalon.com	12.5%
{first name}.{last name}	john.doe@tevapharm.com	2.5%

Key Contacts at Cephalon

Michael Cunnane

Director Global Procurement

Charlene Tucker

Sr. Director & Group Leader, Regulatory Medical Writing

Greg Martin

Retired Director Of Scientific Information

Sheila A. Mathias

Director, Regulatory Affairs

Brigette Speights

Director Regulatory Cmc

Frédérique Baton

Director Clinical Research Oncology Europe

Robert Bellucci

Senior Director Strategic Accounts And Advocacy

Paul Planz

Sr Director Worldwide Engineering

Grace Chiu

Associate Director, Franchise Management, Asia Pacific

Carol Marchione

Sr. Director And Group Leader, Regulatory Affairs

Company overview

Headquarters	United States
Phone number	+16103440200
Websites	cephalon.com tevapharm.com cephalon.dk
NAICS	3254
Keywords	Active Pharmaceutical Ingredients, Quality Healthcare, Generic Medicines, New Therapeutic Entities, Pharmaceutical Research & Development, Specialty Branded Medicines
Employees	501-1000
Socials

About Cephalon

Follow the Teva Pharmaceuticals company page www.linkedin.com/company/teva-pharmaceuticals for information, career opportunities and the latest company updates. Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. In October 2011, Cephalon was acquired by Teva Pharmaceuticals, and is now a wholly owned subsidiary. The combination of companies has enabled Teva to deliver exceptional value for patients and customers across many therapeutic areas. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.